Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 10:55 am Sale |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Stonepine Capital Management, LLC | 6,940,000 3.100% |
-2,971,577 (-29.98%) |
Filing History |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
BlackRock Inc. BLK |
15,101,281 6.900% |
9,347,461 (+162.46%) |
Filing History |
| 2022-12-09 5:00 pm Sale |
2022-12-09 | 13D | ADMA Biologics, Inc. ADMA |
Caligan Partners LP | 10,264,311 4.600% |
-628,926 (-5.77%) |
Filing History |
| 2022-06-28 4:38 pm Purchase |
2022-06-21 | 13G | ADMA Biologics, Inc. ADMA |
Integrated Core Strategies (US) LLC | 6,254,409 3.200% |
6,254,409 (New Position) |
Filing History |
| 2022-02-14 8:55 pm Unchanged |
2021-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Perceptive Advisors LLC | 11,933,387 6.100% |
0 (Unchanged) |
Filing History |
| 2022-02-14 1:52 pm Unchanged |
2020-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Consonance Capital Management LP | 1,558,290 1.650% |
0 (Unchanged) |
Filing History |
| 2022-02-14 08:21 am Sale |
2021-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Stonepine Capital Management, LLC | 9,911,577 5.100% |
-61,300 (-0.61%) |
Filing History |
| 2022-02-11 2:39 pm Purchase |
2021-12-31 | 13G | Terex Corporation TEX |
NWQ INVESTMENT MANAGEMENT COMPANY LLC | 10,612,600 5.420% |
10,612,600 (New Position) |
Filing History |
| 2022-02-04 08:30 am Purchase |
2022-02-03 | 13D | ADMA Biologics, Inc. ADMA |
Caligan Partners LP | 10,893,237 5.600% |
10,893,237 (New Position) |
Filing History |
| 2021-12-30 12:26 pm Purchase |
2021-12-28 | 13G | ADMA Biologics, Inc. ADMA |
Stonepine Capital Management, LLC | 9,972,877 5.100% |
9,972,877 (New Position) |
Filing History |
| 2021-10-27 09:16 am Sale |
2021-10-22 | 13G | ADMA Biologics, Inc. ADMA |
Perceptive Advisors LLC | 11,933,387 6.600% |
-4,651,415 (-28.05%) |
Filing History |
| 2021-04-09 6:02 pm Purchase |
2021-03-31 | 13G | ADMA Biologics, Inc. ADMA |
BlackRock Inc. BLK |
5,753,820 4.700% |
330,121 (+6.09%) |
Filing History |
| 2021-02-16 3:37 pm Purchase |
2020-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Perceptive Advisors LLC | 16,584,802 17.500% |
500,000 (+3.11%) |
Filing History |
| 2021-02-16 2:11 pm Sale |
2020-12-31 | 13G | ADMA Biologics, Inc. ADMA |
Consonance Capital Management LP | 1,558,290 1.650% |
-3,608,671 (-69.84%) |
Filing History |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | ADMA Biologics, Inc. ADMA |
BlackRock Inc. BLK |
5,423,699 5.700% |
1,250,938 (+29.98%) |
Filing History |